FDA PMA FDA Class 3 Approved 🇺🇸 United States

Implant, Intragastric For Morbid Obesity

PMA: P140008 · Supplement: S028 · Decision Jan 5, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0

Basic Information

Device Name
Implant, Intragastric For Morbid Obesity
Trade Name
ORBERA INTRAGASTRIC BALLOON
PMA Number
P140008
Supplement Number
S028
Device Class
FDA Class 3
Product Code
LTI
Generic Name
IMPLANT, INTRAGASTRIC FOR MORBID OBESITY
Medical Specialty
Unknown
Advisory Committee
Gastroenterology, Urology
Decision
Approved
Decision Code
APPR
Decision Date
January 5, 2026
Date Received
November 20, 2025
Supplement Type
Normal 180 Day Track No User Fee
Supplement Reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

a manufacturing site change to replace the Apollo Endosurgery Coyol, Costa Rica facility with the Boston Scientific Coyol, Costa Rica facility for the Orbera Intragastric Balloon, following acquisition of Apollo Endosurgery by Boston Scientific

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LTI Implant, Intragastric For Morbid Obesity